What is Sutphin RLD?
Sutphin RLD, operating as Sutphin Drugs Inc., specializes in the procurement of reference listed drugs (RLD), comparator drugs, and innovator drugs originating from the USA. These critical supplies are destined for use in clinical trials. The company caters to clients engaged in clinical research and product development, ensuring strict adherence to FDA guidelines for drug storage and quality monitoring. Sutphin RLD offers adaptable shipping solutions, accommodating various temperature controls and utilizing established courier services. It is recognized as a premier supplier within its industry, with participation noted at events like Expo Pharm 2025.
How much funding has Sutphin RLD raised?
Sutphin RLD has raised a total of $145K across 1 funding round:
Debt
$145K
Debt (2021): $145K with participation from PPP
Key Investors in Sutphin RLD
PPP
Public-Private Partnership
What's next for Sutphin RLD?
With a substantial total funding of $145K and a recent strategic investment of $145K, Sutphin RLD is well-positioned for its next phase of growth. The company's focus on sourcing essential drugs for clinical trials, coupled with its commitment to regulatory compliance and flexible logistics, suggests a strategic expansion into new markets or an enhancement of its service offerings. This late-stage funding likely supports scaling operations, broadening its supplier network, and potentially investing in advanced supply chain technologies to further solidify its leadership in the pharmaceutical supply sector.
See full Sutphin RLD company page
